Katrina Thornber, Author at European Medical Journal - Page 9 of 35

New Oral Regimens Shorten Rifampin-Resistant Tuberculosis Treatment

New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.

Breakthrough Blood Test Offers Hope for Early Pancreatic Cancer Detection

A new blood test, PAC-MANN, shows promise for early detection of pancreatic cancer, improving treatment options and survival rates.

A New Way to Improve Melanoma Immunotherapy

Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

OCEAN(a)-DOSE Trial: New Data on Lipoprotein(a) and Oxidised Phospholipids

Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.

Self-Healing E-Skin Recovers in 10 Seconds, Transforming Biometric Wearables

A new self-healing E-Skin recovers within 10 seconds, enabling AI-assisted real-time health monitoring in extreme conditions.

Promising Results for ACURATE neo2 TAVI in Bicuspid Aortic Valve Stenosis

ACURATE neo2 TAVI shows strong 30-day outcomes in severe bicuspid aortic stenosis, with high device success and safety.

Extended Pelvic Lymph Node Dissection Linked to Lower Metastasis Risk in Prostatectomy

Extended pelvic lymph node dissection during prostatectomy significantly reduces metastasis risk, new study finds.

Extreme Temperatures Raise Mortality Risks for Patients with COPD

Extreme temperatures significantly increase morbidity and mortality risks for patients with chronic obstructive pulmonary disease.

Hormonal Influence on Background Parenchymal Enhancement in CEM

Hormonal factors significantly influence the degree of background parenchymal enhancement (BPE) in CEM, study finds.

Study Links Delayed REM Sleep to Early Alzheimer’s Risk

Delayed REM sleep may indicate early Alzheimer’s, with longer REM latency linked to increased toxic protein levels and reduced neuroprotective factors.